Vincristine sulfate for Leukemia | MyLeukemiaTeam

Connect with others who understand.

sign up Log in
About MyLeukemiaTeam
Powered By

Vincristine sulfate is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat several types of leukemia, including acute lymphoblastic leukemia (ALL). Vincristine sulfate is often combined with other drugs in chemotherapy regimens.

Vincristine sulfate is an anticancer drug used in chemotherapy and a member of a class of drugs called plant alkaloids. Vincristine sulfate is believed to work by interfering with the structure and division of cancer cells.

How do I take it?
Vincristine sulfate is administered as an intravenous infusion during chemotherapy treatment.

Side effects
The FDA-approved label for vincristine sulfate lists common side effects including hair loss, mouth sores, nausea, diarrhea, vomiting, constipation, loss of appetite, abdominal pain, changes in the sense of taste, peripheral neuropathy (tingling or numbness in the extremities), and low blood cell counts. If vincristine sulfate leaks into the skin or tissue at the injection site, a painful inflammatory reaction may arise.

Rare but serious side effects listed for vincristine sulfate include fetal harm in pregnant women, coronary artery disease, and an increased risk of developing other cancers.

For more details about this treatment, visit:

Vincristine Injection — MedlinePlus

Vincristine Sulfate — National Cancer Institute

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in